Publications

Hannan K, Sherer ML, Osborne LM.  2023.  Vitamin D levels and anxiety symptomatology in pregnancy and the postpartum.. Arch Womens Ment Health. 26(6):857-861.

Osborne LM, Payne JL, Sherer ML, Sabunciyan S.  2022.  Altered extracellular mRNA communication in postpartum depression is associated with decreased autophagy.. Mol Psychiatry. 27(11):4526-4535.

Sherer ML, Voegtline KM, Park H-S, Miller KN, Shuffrey LC, Klein SL, Osborne LM.  2022.  The immune phenotype of perinatal anxiety.. Brain Behav Immun. 106:280-288.

Osborne LM, Gilden J, Kamperman AM, Hoogendijk WJG, Spicer J, Drexhage HA, Bergink V.  2020.  T-cell defects and postpartum depression.. Brain Behav Immun. 87:397-403.

Osborne LM, Yenokyan G, Fei K, Kraus T, Moran T, Monk C, Sperling R.  2019.  Innate immune activation and depressive and anxious symptoms across the peripartum: An exploratory study.. Psychoneuroendocrinology. 99:80-86.

Osborne LM, Betz JF, Yenokyan G, Standeven LR, Payne JL.  2019.  The Role of Allopregnanolone in Pregnancy in Predicting Postpartum Anxiety Symptoms.. Front Psychol. 10:1033.

Osborne LM, Brar A, Klein SL.  2019.  The role of Th17 cells in the pathophysiology of pregnancy and perinatal mood and anxiety disorders.. Brain Behav Immun. 76:7-16.

Osborne LM, Gispen F, Sanyal A, Yenokyan G, Meilman S, Payne JL.  2017.  Lower allopregnanolone during pregnancy predicts postpartum depression: An exploratory study.. Psychoneuroendocrinology. 79:116-121.

Osborne LM, Monk C.  2013.  Perinatal depression--the fourth inflammatory morbidity of pregnancy? Theory and literature review. Psychoneuroendocrinology. 38(10):1929-52.